Literature DB >> 19932071

Chagas disease: a Latin American health problem becoming a world health problem.

Gabriel A Schmunis1, Zaida E Yadon.   

Abstract

Political repression and/or economic stagnation stimulated the flow of migration from the 17 Latin American countries endemic for Chagas disease to developed countries. Because of this migration, Chagas disease, an autochthonous disease of the Continental Western Hemisphere is becoming a global health problem. In 2006, 3.8% of the 80,522 immigrants from those 17 countries to Australia were likely infected with Trypanosoma cruzi. In Canada in 2006, 3.5% of the 156,960 immigrants from Latin America whose country of origin was identified were estimated to have been infected. In Japan in 2007, there were 80,912 immigrants from Brazil, 15,281 from Peru, and 19,413 from other South American countries whose country of origin was not identified, a portion of whom may have been also infected. In 15 countries of Europe in 2005, excluding Spain, 2.9% of the 483,074 legal Latin American immigrants were estimated to be infected with T. cruzi. By 2008, Spain had received 1,678,711 immigrants from Latin American endemic countries; of these, 5.2% were potentially infected with T. cruzi and 17,390 may develop Chagas disease. Further, it was estimated that 24-92 newborns delivered by South American T. cruzi infected mothers in Spain may have been congenitally infected with T. cruzi in 2007. In the USA we estimated that 1.9% of approximately 13 million Latin American immigrants in 2000, and 2% of 17 million in 2007, were potentially infected with T. cruzi. Of these, 49,157 and 65,133 in 2000 and 2007 respectively, may have or may develop symptoms and signs of chronic Chagas disease. Governments should implement policies to prevent donations of blood and organs from T. cruzi infected donors. In addition, an infrastructure that assures detection and treatment of acute and chronic cases as well as congenital infection should be developed. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19932071     DOI: 10.1016/j.actatropica.2009.11.003

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  247 in total

1.  Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera.

Authors:  Cristina Riera; Mireia Verges; Laura Iniesta; Roser Fisa; Montserrat Gállego; Silvia Tebar; Montserrat Portús
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Chagas disease: assessing the existence of a threshold for bug infestation rate.

Authors:  Hirotsugu Aiga; Emi Sasagawa; Ken Hashimoto; Jiro Nakamura; Concepción Zúniga; José Eduardo Romero Chévez; Hector Manuel Ramos Hernández; Jun Nakagawa; Yuichiro Tabaru
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

Review 3.  Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Authors:  Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

4.  Moderate physical exercise reduces parasitaemia and protects colonic myenteric neurons in mice infected with Trypanosoma cruzi.

Authors:  Neide M Moreira; Franciele d N Santos; Max Jean d O Toledo; Solange M F d Moraes; Eduardo J d A Araujo; Debora d M G Sant'Ana; Silvana M d Araujo
Journal:  Int J Exp Pathol       Date:  2013-11-01       Impact factor: 1.925

5.  Prevalence of Chagas Disease among Solid Organ-Transplanted Patients in a Nonendemic Country.

Authors:  Fernando Salvador; Adrián Sánchez-Montalvá; Elena Sulleiro; Francesc Moreso; Cristina Berastegui; Mireia Caralt; María-Jesús Pinazo; Zaira Moure; Ibai Los-Arcos; Oscar Len; Joan Gavaldà; Israel Molina
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

6.  Performance Assessment of a Trypanosoma cruzi Chimeric Antigen in Multiplex Liquid Microarray Assays.

Authors:  Fred Luciano Neves Santos; Paola Alejandra Fiorani Celedon; Nilson Ivo Tonin Zanchin; Amanda Leitolis; Sandra Crestani; Leonardo Foti; Wayner Vieira de Souza; Yara de Miranda Gomes; Marco Aurélio Krieger
Journal:  J Clin Microbiol       Date:  2017-07-19       Impact factor: 5.948

7.  Perturbed T cell IL-7 receptor signaling in chronic Chagas disease.

Authors:  M Cecilia Albareda; Damián Perez-Mazliah; M Ailén Natale; Melisa Castro-Eiro; María G Alvarez; Rodolfo Viotti; Graciela Bertocchi; Bruno Lococo; Rick L Tarleton; Susana A Laucella
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

Review 8.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

9.  Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.

Authors:  Aparecida D Malvezi; Carolina Panis; Rosiane V da Silva; Rafael Carvalho de Freitas; Maria I Lovo-Martins; Vera L H Tatakihara; Nágela G Zanluqui; Edecio Cunha Neto; Samuel Goldenberg; Juliano Bordignon; Sueli F Yamada-Ogatta; Marli C Martins-Pinge; Rubens Cecchini; Phileno Pinge-Filho
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

10.  Seroprevalence of Trypanosoma cruzi Infection in Schoolchildren and in Pregnant Women from an Amazonian Region in Orellana Province, Ecuador.

Authors:  Caty Carrera Vargas; Alberto Orlando Narváez; Jenny Muzzio Aroca; Gonzalo Shiguango; Luiggi Martini Robles; Claudia Herrera; Eric Dumonteil
Journal:  Am J Trop Med Hyg       Date:  2015-08-17       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.